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It has been proposed that  the chronic  inflammatory process of rheumatic 
diseases is the direct result of the persistence in tissue of toxic mucopeptide-C 
polysaccharide complexes from Group A streptococcal cell wails (1-3). In this 
concept,  the  tissue damage is produced by the direct  toxicity of the muco- 
peptide moiety. This is supported by the observation that the isolated muco- 
peptide can induce  a  severe acute necrotic reaction,  and the degree of acute 
toxicity is inversely related to the amount of residual polysaccharide (2). The 
polysaccharide,  therefore, plays the  dual  role  of protecting the mucopeptide 
from tissue lysozyme and masking the toxic property. Thus, the cell wall frag- 
ments can persist in  tissue in a  relatively innocuous state,  and  as the poly- 
saccharide is gradually removed by tissue enzymes the mucopeptide is exposed 
to produce chronic irritation. 
One experimental model of this toxicity is a chronic,  relapsing  nodular lesion 
of the dermal connective tissue of rabbits which occurs over a period of at least 
92 days following a single injection of a preparation of Group A streptococcal 
cell walls (3, 4). Chronic inflammatory lesions showing a comparable histologic 
process also have been produced in rabbit knee joints (1, 5), and mouse hearts 
(6).  The joint lesions were produced by the intra-articular  injection of sterile 
cell wall fragments and the active inflammation was demonstrable for at least 
6 wk. Granulomatous lesions involving valves and myocardium were produced 
by intraperitoneal injection of much larger doses (about 10 rag) of the cell wall 
fragments. 
Heretofore, we have had only indirect evidence that the chronic lesions pro- 
duced with streptococcal cell walls in these various models are directly related 
to persistence of cell wall material. This paper describes the relationship of the 
injected cell wall antigens to the various phases of the relapsing nodular lesion 
* Supported  by  Research  Grant  AI  00949  from  the National Institute of Allergy and 
Infectious Diseases, United States Public Health Services, Bethesda, Md. 
~/Supported by United States Public Health Service Training Grant GM 01138. 
1137 1138  GROUP  A  STREPTOCOCCAL CELL WALLS AND  INFLAMMATION 
of rabbit skin.  Specific antibodies against both mucopeptide (7)  and  C  poly- 
saccharide have been labeled with fluorescein or l~sI, and the fate of the antigens 
was followed by fluorescence microscopy and radioautography. 
The  studies  described  here  provide  the  basis  for  investigations  currently 
being conducted on the persistence and localization of cell wall material in the 
experimental models of joint and heart, as well as human material from patients 
with rheumatoid  arthritis or rheumatic heart disease. These  experiments are 
designed to determine as definitively as possible the significance of toxic cell 
wall fragments in the pathogenesis of connective tissue diseases. 
This study also involves the problem of disposal of intact bacterial cells in 
tissue  and  the  nature  of  the  products  of  digestion.  We  are  specifically con- 
cerned with the question of whether or not potentially toxic cell wall fragments 
can be released in the natural process of dismantling the cell in vivo. 
Materials and Methods 
Inlaa Strepwco~i.--lO0  ml of a  16 hr Todd-Hewitt broth culture of  Group A strepto- 
cocci, strain D-58, Type 3 was washed two times with saline at 4°C. The washed packed cells 
were resuspended in 5-ml sterile pH 6.0 phosphate-buffered  saline (0.01 ~ phosphate, 0.14 ~t 
NaCI) and killed by heating at 60°C for 30 rain.  No viable organisms could be detected by 
stre~'tklng 0.1 ml of the suspension onto sheep blood agar plates. Prior to injection, the sus- 
pension was diluted to contain the equivalent of 10 #g of cell wails in 0.2 mlpH 5.0 phosphate- 
buffered saline (laBS). Higher concentrations of killed bacteria, or the use of viable organisms, 
produced a necrotic reaction too severe for reliable detection of antigens. 
Cell Wall Fragments.--Cell wall fragments from  Group A streptococci,  strain D-58 were 
prepared by sonic disruption of cells in a Raytheon 9KC sonic oscillator as previously de- 
scribed (8). The cell wall fragments were treated with 0.026% trypsin at 37°C, washed with 
buffered saline,  and sterilized by graded filtration through 5.0, 3.0,  1.2, and finally 0.45 
millipore membranes.  Cell wall fragments from  Group  D, strain F-24 streptococci were ob- 
tained by treatment of a cell wall preparation for 60 min in the Raytheon sonic oscillator. 
The cell wall preparation was obtained by disrupting a washed cell suspension in the Braun 
M  S K  cell homogenizer. The collection and washing of this cell wall preparation has been 
described  (8). The Group D cell walls were not treated with trypsin because of the autolysis 
observed with these preparations. Prior to injection, the suspensions were diluted with sterile 
laBS to contain 240 #g cell walls per 0.2 ml. 
Antisemm.--New Zealand white rabbits were immunized  intravenously with a  Group A 
Type 3, strain D-58  vaccine according  to  the procedure of McCarty and Lancefield  (9). 
The cells were grown in trypticase-soy broth (Baltimore Biological Laboratories, Baltimore, 
Md.), washed three times with saline, and treated with 0.001% trypsin for 4 hr at 37°C. They 
were then washed two times with saline, resuspended in saline to 20 times the original broth 
concentration,  and held at 62°C for 30 min. The strain used in our studies has no typable M 
protein but was identified as a Type 3 organism by T protein and recovery of M protein by 
mouse passage by Mr. W. R. Maxted, Colindale Laboratory, London, England. 
Antigens.--Cell  walls from Group A streptococci strain D-58 were prepared as previously 
described  (8)  except  that  the cell suspension was disrupted by a  3  min treatment in the 
Braun M  S K  cell homogenizer. Mucopeptide (MP) was prepared  from  ribonudease- and 
trypsin-treated cell walls by the hot formamide  method of Krause and McCarty (10). The 
group-specific  C  polysaccharide (Cla)  was  precipitated from  the  first formamide extract 
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tide contained 12% nitrogen and less than 1% rhamnose. R.hamnose  and nitrogen were de- 
terminal  by  methods  previously  described  (8). 
125I An~-C Polysac£]~rsd~ (Ant/-CP).--Anti--C polysacclmride was precipitated from the 
antiserum with the C polysaecharide antigen. The precipitates were washed three times with 
cold saline and  dissociated  in 5.0 mlpH 2.75  glycine-HCl-buffered saline for 3 hr at room 
temperature  with  constant  stirring.  Insoluble material was  removed by eentrifugation at 
37,000 g for 60 rain at 22°C, The globulin and C polysaccharide were separated on a 2.5 X  33 
cm  Sephadex  O-100 column equilibrlated with the glycine buffer. The eluted protein was 
dialyzed against phosphate-buffered saline, pH 7.2.  The final yield was 30~o  of the initial 
antibody. This preparation was labeled with 125I as described below. 
1251 Antimucopeptide (Anti-MP).--Before any of the sera  were  absorbed  with mucopep- 
tide or applied to tissue sections, they were absorbed with bentonite to remove any lysozyme 
that might be present. One absorption with 5 mg bentonite per ml serum was carried out at 
17°C  for 1 hr. Quantitative preeipitin tests showed bentonite absorption did not affect the 
precipitating ability of the antiserum with either MP or CP. 
The antimucopeptide was precipitated  from  the antiserum  which had  previously been 
absorbed with C polysaccharide and bentonite.  Mucopeptide was added in several steps to a 
total concentration of 2  mg per ml serum. The washed  precipitates were dissociated with 
giycine buffer  as described  for anti-CP.  The insoluble mucopeptide  fragments were  sepa- 
rated from the globulin by centrifngation at 37,000 g for 60 rain at 22°C. The superuatant 
was dialyzed against  PBS,  pH 7.2.  The  yield was  25-30~o  and  the  globulin  was  97% 
specific  antimucopeptide.  Immunodiffusion and  immunoelectrophoretic procedures  demon- 
strated  that  the  specific  anti-MP  and  anti-CP  were  "gG-giobulins.  That  is,  they  gave 
lines of identity with DEAE-prepared TG-globulin in Ouchterlony plates, and the immuno- 
electrophoretic pattern and sedimentation rate were consistent with rabbit ~/G-globulins. 
Normal Globulin.--Pooled normal rabbit serum was absorbed with bentonite and mucopep- 
tide, the latter to remove small concentrations of "normal"  antibody. The globulin fraction 
was twice precipitated with (NH4)~SO~ at 50% saturation.  The  precipitate  was  dissolved 
in PBS pH 7.2 and dialyzed against buffer. This crude globulin was labeled with either l~SI 
or flnorescein as described below. 
Fluorescein-Labded Anti-Group  A  Streptococcus Globulin (FITC anti-A  Globulin).~The 
globulin fraction was twice precipitated from antiserum at 50% saturation with (NI-I4)2SO4. 
This  was  conjugated  with  fluorescein  isothiocyanate  (Baltimore  Biological Laboratories) 
using the procedure of Marshall, Eveland, and Smith (12). The unconjugated fluorescein was 
removed by filtration on a Sephadex G-25 column equilibrated with pH 7.2 phosphate buffer. 
Fluoresceln-Labded Anti-C Polysaccharide (FITC anti-CP).--The globulin fraction from 
antiserum absorbed with bentonite and mucopeptide was obtained by (NI-I4)2SO4 precipita- 
tion at 50% saturation. This was conjugated with fluorescein as described above. 
Fluorescein-Labded Antimucopeptide (FITC anti-MP).--The globulin fraction from anti- 
serum absorbed with C  polysaccharide was  obtained  by  (Ntt4)~SOa  precipitation at  50°70 
saturation. This was conjugated with fluorescein as described above. These globulin prepara- 
tions were used in the fluorescein technique, instead of purified eluted antibodies, because of 
the relatively high degree of denaturation of the dilute purified antibody in the fluorescein- 
labeling procedure. 
I odination of Antibody and Normal Globulin with 125L--The specific anti-MP, anti-CP, and 
normal globulin were labeled using a modification of the NaNO~ procedure of Johnson, Day, 
and Pressman (13). The labeling was carried out to give an average of 1-2 atoms iodine per 
protein molecule. After removal of unbound  iodine by dialysis 2.5 mg/ml bovine plasma al- 
bumin and ~'~o.ooo merthiolate were added.  This  mixture was  sterilized by H/k  milllpore 
filtration and stored in the cold. The specific activity of 1~5I anti-MP,  t25I  anti-CP, and  125I 
normal globulin were respectively 30.5 tic/rag, 44 gc/mg, and 54/~c/mg. 1140  GROUP  A  STREPTOCOCCAL CELL  WALLS AND  INFLAMMATION 
Injection of Rabbits and Nodular Lesion Produaion.--Three groups of New Zealand  white 
rabbits weighing approximately 2.0-2.5 kg were used in the experiments. Group I contained 26 
rabbits, group II contained 38 rabbits, and group III contained 39 rabbits. All animals were 
fed Purina rabbit chow and water ad Ubitum. 
Group 1: Nine rabbits served as controls, seven of these were injected intradermally with 
0.2  ml sterile PBS pH 6.0,  and two served as normal uninjected controls. The remaining 16 
were injected intradermally  with 0.2  ml suspension  of intact  heat-killed Group A strepto- 
cocci in sterile PBS pH 6.0. This group of rabbits was examined for the presence of strepto- 
coccal antigens using FITC anti-A globulin and FITC normal globulin. 
Group II: 4 of the 38 rabbits served as controls, 3 were injected with pH 6.0 buffer, and 
the 4th was a  normal control. The remaining 34 rabbits were injected with streptococci as 
described above. This group of rabbits was examined for the presence of MP and CP, using 
FITC anti-MP, anti-CP, and FITC normal globulin as wet1 as the l~I-labeled protein solu- 
tions. 
Group III: Six rabbits  served as controls, five were injected intradermally with 0.2  ml 
sterile Group  D  cell wall fragments.  The remaining 32  received 0.2  mi of sterile  Group A 
wall fragments.  The latter rabbits  developed chronic  relapsing  multinodular  lesions. This 
group was examined using reagents as described for group II. 
Collection and Storage of Skin samples.--Rabbits were killed by cervical dislocation and 
samples obtained by making an incision which cut the site in half; each half was trimmed to 
about  2  X  5 mm and snap frozen by dipping into liquid propane cooled to  -170°C with 
liquid nitrogen.  The frozen samples were stored  in screw-cap vials at  -70°C  until frozen 
sections were prepared. 
In the group I  buffer-injected control animals, skin samples were taken at 0, 2, 4, 8, and 
12 hr,  1 day, and 2 days after injection. Samples were obtained from the experimental rab- 
bits at 0, 2, 4, 8, and 12 hr; and 1, 2, 3, 4, 5, 6, 8, 10, 12, 15, and  18 days after injection of the 
streptococci. One rabbit was taken at each time interval. 
In group II, the buffer-injected samples were obtained at 8 hr,  1 day, and 3 days after 
injection. Samples were obtained from experimental rabbits at 4 hr [1], 8 hr [1], 1 day [1], 
3  days [3], 5 days [3], 8 days [2], 10 days [3], 15 days [3], 18 days [3], 21 days [3], 42 days 
[3], 56 days [3], 84 days [2], 112 days [2], and  168 days [2] after injection. The numbers in 
brackets represent the number of rabbits taken at each time interval. 
Group III represents the rabbits which developed nodular lesions.  The control samples, 
from rabbits injected with Group D  cell walls, were taken at 8 hr [2], 1 day [2], and 3 days 
[1]  after injection. Samples from the experimental animals were removed at 4  hr  [2], 8  hr 
[2], 1 day [2], 3 day [2], at the time of the early primary nodular lesion  [2], primary nodular 
lesions  [2], subsiding  primary  nodular  lesion  [2], early  healed  primary  nodular  lesion  [2], 
late healed primary nodular lesion [2], early relapsed (secondary) nodular lesions [2], relapsed 
nodular lesion [3], subsiding relapsed nodular lesions [3], late healed relapsed nodular lesion 
[2], no nodular lesion formation at any time up to 54 days [2], primary nodular lesion only 
and no further gross reaction up to 54 days [1]. 
Fluoresc~t Antibody  S~ining---4-/z  frozen sections were prepared  and immediately fixed 
for 30-60 rain in absolute methanol Prior to staining with fluorescein-labded proteins some 
of the sections were incubated in 0.1 ~ HC1 for 30 rain at room temperature and washed with 
PBS pH 7.1.  This acid treatment greatly decreased the incidence of nonspecific  staining of 
the inflammatory tissue, presumably by removing basic proteins from PMN lyso~.omes. Non- 
specific  staining was also controlled by absorbing  the  FITC conjugates  twice with  rabbit 
liver powder according to the procedure of Coons and Kaplan (14). 
In the study involving the group I  rabbits the reagents used were FITC anti-A globulin 
and FITC normal globulin. The labeled antibody was diluted to contain 5/~g fluoreseein per 
ml and 0.1 ml was applied to the sections and incubated for 30 rain in a humidified chamber SARKIS  H.  0HANIAN  AND  JOHN  H.  SCHWAB  1141 
at room temperature. The sections were washed four times with PBS pH 7.1,  10 mill each 
time, and mounted with 90% buffered glycerin. Controls included blocking with homologous 
anti-A serum, staining with conjugated normal globulin, and sections from buffer-injected 
and normal uninjected rabbits. 
In the rabbits of groups II and III, those sections which were to be stained with the FITC 
anti-MP reagent were incubated with undiluted, bentonite and MP-absorbed, anti-A serum 
for 1 hr in a humid chamber at room temperature. After washing 10 min with two changes of 
PBS, 0.1 ml of the diluted FITC anti-MP reagent was applied and the section treated as 
described above. When the FITC anti-CP reagent was used, the sections were preincubated 
with undiluted, bentonite and  CP-absorbed, anti-A serum. 
Fluorescence microscopy was carried out with a  LeiC.z Ortholux microscope fitted with a 
HB0200 mercury vapor lamp; heat filters, 4 mm BG38 and 2 mm KG1; exciter filter, 3  mm 
BG12; Leitz darkfield condenser NA  1.20;  10 X  eyepiece ftted with a  2.5 mm OG1 barrier 
filter. 
Radioautography Procedure.--4-#  frozen sections were fixed in absolute methanol, air dried, 
wetted  with PBS,  and preincuhated  1 hr at  room  temperature in a  humid chamber with 
undiluted, bentonite and  MP-absorbed,  normal serum.  Following two  5  rain washes with 
PBS approximately 4 #g of the iodinated antibodies or normal globulin contained in 0.1 ml 
of 50% normal serum (1:1 with pH 7.1 PBS) was applied to the section and incubated 30 rain 
at room tempbemture in a humid chamber. The sections were washed four times with PBS, 
10 rain each, and coated with NTB-2 Nuclear Tract Emulsion (Eastman Kodak Co., Roches- 
ter, N. Y.). The coated slides were placed in a  Conrad Joftes radioautography chamber and 
exposed to a low humidity and COs atmosphere for 7-9 days at  room temperature. 
Controls consisted of blocking with unlabeled specific antibody;  use of iodinated normal 
globulin; and skin sections from buffer-injected, Group  D  streptococcal cell  wall-injected, 
and normal animals. 
Radioautographs were developed at  18 4-  I°C  for 4  min with D-19 developer  (Kodak), 
rinsed 15 sec with Kodak SB5 stop bath, fixed for 10 min in acid fixer, and rinsed thoroughly 
in running water. 
Staining Methods.--After examining  the  fluoresceiu-labeled  sections  and  recording  the 
location of the areas of interest the cover slips were carefully removed by immersion in abso- 
lute methanol and stained with Giemsa stain. After development of the radioautograph slides 
they were stained through the emulsion with Giemsa in pH  5.75  citrate-phosphate buffer. 
A  tissue section from each skin sample was also stained with hematoxylin and eosin. 
Photography.--Fluorescent antibody pictures were  taken with a  Polaroid  MP-3  camera 
using type 410 (10,000 ASA) film. Brightfield pictures were made using type 42  (200 ASA) 
film. 
RESULTS 
Injection o/Intact Streptococci and Detection of Antigens with anti-A globulin. 
--Within the first 4 hr after injection the majority of streptococci were within 
polymorphonuclear  leukocytes  (PMN).  Neither  the  intra-  or  extracellular 
bacteria  were  altered  significantly  in  morphology from  their  characteristic 
chain of cocci, and fuorescence was clearly associated with identifiable cocci 
(Figs. 1 a  and 1 b). Labeling of streptococci did not occur after absorption of 
FITC anti-A globulin with intact streptococci. The greatest change occurred 
at 24 hr.  By this  time the  total fluorescence in the  site had decreased con- 
siderably and many of the coccal chains had been broken down to small fluores- 1142  GROUP  A  STREPTOCOCCAL  CELL  WALLS  AND  INFLAMMATION 
cent particles in PMN. This was the earliest time at which fluorescent material 
could not be associated with morphologically recognizable streptococci. 
By the 2nd-3rd day after injection no streptococci could be identified mor- 
phologically. In Giemsa-stalned sections most of the  cells were mononuclear 
and  contained granular material.  This  was  apparently streptococcal antigen 
since  it  corresponded with  the  pattern  of granular  fluorescence with  FITC 
anti-A globulin. 
The necrotic area increased in size up to day 5 or 6. During this time very 
large monocytes appeared which contained the cytoplasmic granular material. 
At about 8 days the size and number of cells began to decrease. At 18-21 days 
a few mononuclear cells were found to contain small inclusions on staining with 
Giemsa. Correlating with this histological subsidence, the total fluorescence of 
the site, as well as the number of cells containing fluorescent material, decreased 
slowly. From days 5 to 18 the nature of the phagocytized fluorescent material 
did not change (Figs.  1 c and 1 d). 
The buffer-injected control sections displayed a mild inflammatory response 
which was  essentially gone by the  2nd  day.  These samples  contained a  few 
fluorescent cells but  this  was  not  associated  with  streptococcal antigen,  as 
determined by examination of the controls. 
Persistence of Mucopeptide and C Polysaccharide  following Injection of Intact 
Streptococci.--In the study involving the group II rabbits both the fluorescent 
and radioautographic procedures were employed. The FITC anti-MP,  FITC 
anti-CP, and FITC normal globulins were used in the fluorescent procedures. 
Fluorescent Antibody Procedure.--4 hr after the injection of intact strepto- 
cocci, no MP was detected and only a low level of fluorescence was observed 
with anti-CP reagent. By 8 hr both MP and CP could be detected without 
difliculty. The characteristic chain of fluorescent rings was seen and most were 
intracellular. The controls exhibited very few fluorescent cells. 
As the necrotic process developed and subsided both MP and CP could be 
detected. However, between 1 and 3 days after injection the physical nature of 
the fluorescent labeled material had changed from the characteristic rings to the 
amorphous granular fluorescence noticed with the FITC anti-A globulin. No 
MP or CP could be detected after 21 days although the histology of the tissue 
at 42 and 56 days did not approach normal. 
Radioautograptdc Procedure.--Mter  4  hr  in  vivo,  MP  and  CP  could  be 
detected both intra- and extracellularly. Partially labeled streptococcal chains 
were seen with more frequency when stained with the anti-MP antibody than 
with  the  anti-CP  antibody.  In  sections labeled with  the  latter  reagent  the 
degree of label was higher. There was an indication in the 8 hr samples that the 
degree of labeling of MP and CP had increased over that seen at 4  hr.  The 
number of unlabeled streptococcal chains was very low. 
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crease until 21 days when no MP or CP could be detected. Likewise, in the 42- 
to 168-day samples, no MP or CP could be detected. Figs. 2 a-2 f  illustrate 
the presence of MP and CP at 5 and 18 days and their absence at 21 days. 
Nodular Lesion Formation  following  Injection of Group A Cell Wall Fragments 
(Group III).--Between  8  and  24  hr  after  injection  the  initial edema  and 
erythema reached  maximum intensity. This subsided by the 2nd or 3rd day. 
In 2 of the 33 rabbits no further gross reactions  were seen. In the remaining 
animals firm, red nodules appeared between days 3 and 5, at and around the 
injection site. Nodular lesions varying in size up to 40 X 40 mm and 6 mm in 
height were usually reached within 24-48 hr after they first appeared.  Some 
animals developed multinodular lesions containing as many as six nodules. By 
days 6 and 7 the nodules started to subside and depending on the size of the 
lesion, completely subsided by day 10 or 12. 
Relapsing,  (secondary) nodular lesion formation developed between the 14th 
and 40th day. The nodules usually developed in areas previously involved with 
the primary nodular lesion. The greatest intensity was reached within 48 hr 
after first appearing and was generally less than the primary nodules. Complete 
subsidence varied from 6 to 14 days after the development of the nodules. One 
animal did not develop a secondary nodular lesion. 
Control rabbits injected with Group D  cell wall fragments exhibited  only 
erythema and edema which subsided by day 2. Nodular lesions did not develop 
in these animals. 
Histology of Sites Injected with Group A Cell Wall Fragments.--In the period 
from 2 to 24 hr the connective  tissue  appeared  swollen and contained many 
PMN's and relatively few mononuclear cells. At day 3 the PMN's  had been 
almost completely replaced  by mononuclear  cells. Cellular  and  tissue  debris 
was  minimal and  collagen  bundles  appeared  undamaged except  where  the 
initial edematous process had taken place. Grossly the site appeared normal at 
this time. As primary nodular lesion developed, the collagen bundles were found 
to be swollen and fragmented. Many PMN foci surrounded by large and small 
mononuclear cells were evident during the nodular lesion process  (Figs. 3 a 
and 3 b). The lesions extended from the epidermis to the deep portion of the 
dermis adjacent to the pasmiculus carnosus.  Tissue  and cellular  debris  were 
evident as the lesions subsided. 
In the early and late subsided primary nodular lesion samples, taken at 1 
and 3 days respectively after the lesions had completely subsided, many fibro- 
blast and large and small mononuclear cells were seen throughout the connec- 
tive tissue. Most of the mononuclear cells were located in the reticular layer of 
the dermis. During the development,  peak, and subsidence of the secondary 
nodular lesion the events resembled those of the primary nodular lesion except 
on a smaller scale. 
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formation by 54 days, a few collections of mononuclear cells were seen in an 
otherwise normal skin.  The sections from the rabbit which produced only a 
primary nodular lesion contained small loci of cells throughout the connective 
tissue.  These included fibroblasts as well as large and small mononuclear cells. 
The rabbit had been grossly negative for 30 days before the sample was taken. 
Thrombosis of vessels was minimal in all of the sections examined. 
Group D Call Wall ControL--The  early inflammatory process paralleled that 
described in the nodular lesion section above. By the 3rd day, except for the 
slightly different morphology of the connective tissue at the site,  the sections 
were indistinguishable from normal skin. 
Persistence of MP and CP in Sites Injected with Cell Wall Fragments.--Since 
both the fluorescent and radioautographic procedures gave similar results, only 
those from the latter will  be presented. The acute inflammatory response in- 
duced by the Group D  cell walls did not exhibit any specific localization of the 
anti-group  AMP-  or  CP-iodinated  globulins  (Figs.  3 c-3 f).  There was, 
however, a  slightly higher background staining associated with the inflamma- 
tory site.  This control shows that these reagents fail to react nonspecifically 
with inflammatory tissue.  The control samples  taken at day 3  could not be 
differentiated from the normal uninjected control. 
As is illustrated in Figs. 4 a and 4 c, at 4 hr MP and CP could be found both 
phagocytized and extracellular in the tissue injected with Group A cell walls, 
the difference ill the degree of label was due to the different specific activities of 
each of the antibodies. 
The controls are presented in Figs. 4 b, 4 d, and 4 e. Although the label was 
not completely blocked by unlabeled antibody, there was a definite decrease in 
the intensity of silver grains. By day 3, many of the mononuclear cells contained 
the antigens. 
In the primary nodular lesion both antigens were detected. In the late sub- 
sided primary nodular lesion, removed about 4 days after the lesion had com- 
pletely subsided, much of the label was associated with cells in the deep layer 
of the dermis (Figs. 5 a  and 5 b). However, as was true for all samples taken 
after the maximum primary nodular lesion response, fewer cells contained the 
antigens. Both antigens could also be detected within macrophages throughout 
the connective tissue as the secondary nodular lesion developed and reached its 
maximum  (Figs.  5 c and  5 d).  Thus,  in  all  the phases  of the  nodular lesion 
described so far, both MP and CP could be detected. 
In contrast, neither antigen could be detected in either the subsiding (Figs. 
5 e and 5 f) or healed scondary nodular  lesions. The sample from the rabbit 
which produced only a primary nodular lesion also was found not to contain 
MP or CP at 54 days after injection (Figs. 6 e and 6f). This rabbit had been 
negative for 30 days before the  sample  was  taken.  On the other hand,  as is 
illustrated in Figs. 6 a-6 d, the antigens were detected in the samples from the 
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54 days of observation. In all cases where MP and CP were detected they were 
both found in the same area in consecutive sections. 
DISCUSSION 
Our understanding of the mechanism by which host tissue degrades bacterial 
cells is very incomplete. We have even less information on the nature of the 
products of this degradation and their localization and persistance. If the Group 
A  streptococcus is broken down to small soluble components, it is probably 
rapidly excreted with no harm to the host, as Schmidt has demonstrated with 
the isolated group-specific C polysaccharide (15). However, ff large complexes 
of the cell wall are released in the digestive process they may persist in tissue 
producing profound chronic tissue damage. The process of degradation can be 
influenced by many factors, including previous contact. Thus, Humphrey and 
Pagel (16) reported that patients with streptococcal disease tended to degrade 
heat-killed streptococci in a  different manner and rate than normal controls. 
We have suggested that the cardiac lesions of rheumatic fever and certain 
other chronic disorders of connective tissue are due to the localization of bacteria 
with the subsequent release of toxic cell wall complexes at the site of lesion 
development. This is compatible with the selective localization and continued 
tissue injury in the absence of culturable streptococci in human disease (17), 
and in experimentally infected rabbits (18, 19). 
Consistent with this reasoning is the observation in the present study that in 
rabbits injected with intact streptococci the morphologically identifiable cocci 
could no longer be detected after 2-3  days; whereas, cell wall antigens were 
detected 18 days after injection of cells.  This suggests that potentially toxic 
cell wall fragments are released from the streptococcal cell in the process of in 
vivo degradation. 
The results using the specific  anti-MP and anfi-CP reagents to follow cell 
wall antigens after injection of intact cells essentially agrees with the observa- 
tion using the anti-A globulin. Thelatter reagent, of course, contains antibodies 
against at least two additional streptococcal antigens, detectable by immuno- 
diffusion. It is not surprising,  therefore,  that the  amount of labeled anti-A 
globulin reacting with the tissue section decreases steadily over the first 24 hr 
after injection, whereas,  the  amount of monospecific anti-MP  and anti-CP 
reagents reacting with tissue sections increases during the first 8 hr of in vivo 
exposure. This has been confirmed by quantitative in vitro studies in which 
streptococcal cells exposed to lysozome extracts from rabbit PMN, react with 
significantly more l*SI-labeled anti-MP and anti-CP compared to control cell 
suspensions in buffer.  1 The reaction of cells with 12~I-labeled normal globulin 
was not affected by this treatment. In other experiments (1) smears of in vitro 
grown streptococci were shown to react poorly with anti-MP, compared with 
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cocci in tissue sections from skin sites injected 4 hr previously. These results are 
interpreted to mean that, although this strain has no typable M protein, there 
are antigens superficial to the C polysaccharide as well as to the mucopeptide, 
which partially mask these cell wall components and are readily removed by 
tissue factors. 
In earlier reports on the experimental model of chronic relapsing lesions in 
rabbit skin following injection of cell wall fragments, it was postulated that the 
cell wall material could remain in the tissue and retain its toxic property for a 
relatively long time (1-3). The present paper demonstrates that the cell wall 
components of Group A streptococci can persist in the skin tissue of some rab- 
bits for a period of at least 54 days. In more recent studies, in another series of 
animals observed over a period of 13 wk, relapsing nodular lesions were observed 
in 3 out of 13 surviving rabbits 92 days after injection of 240 #g of isolated cell 
wall fragments. Cell wall antigens could be identified in these lesions at 92 days 
with  l~bI-labeled  anti-MP  and  anti-group  A  variant  reagents,  but  antigen 
having the original group-specific specificity could not be detected.  1 
The persistence of antigen was highly variable between individual rabbits 
and  was  correlated with  the  chronic inflammatory response  of  the  animal, 
rather than the time elapsed after injection. This is supported by the following 
observations:  (a)  Tissue reaction as  reflected in  the nodular skin lesion was 
always associated with detectable cell wall antigens. In addition, as judged sub- 
jectively from the radioautographs, the amount of antigen present in a  tissue 
section was more related to the phase of the inflammatory lesion than to time 
after injection.  For example,  secondary nodular lesions removed from three 
animals at 15, 27, and 42 days after injection all showed similar histology and 
comparable density of silver grains in spite of the wide difference in time lapse. 
(b)  In those animals in which the relapsing nodular lesion activity had com- 
pletely subsided, no antigen was detected. (c) In one animal which displayed 
only a primary nodular lesion with no further tissue reaction, antigen could not 
be detected 54 days after injection. These animals eliminated the cell walls in 
the course of the inflammatory response, and presumably, there would have 
been no further lesion activity regardless of how much longer they had been 
observed. (d) In contrast, in those rabbits which showed no nodular lesion reac- 
tion at any time, considerable amounts of antigen could still be observed in the 
area of injection at 54 days. This indicates that the cell wall material can per- 
sist in some animals for an indefinite period of time until an adequate inflam- 
matory response is invoked. Presumably, these animals eventually would have 
developed lesions, since in other studies with this dose of cell wall material an 
occasional animal would remain completely negative for as long as 8 wk after 
injection and then develop a typical primary nodular lesion followed by exacer- 
bations (3, 4). The fact that Group A cell wall fragments can reside in tissue 
within macrophages for a long period before a tissue response is apparent, is one 
of the most significant observations of this study. SARKIS H.  OHANIAN AND JOHN H.  SCHWAB  1147 
SUMMARY 
Antibodies specific for the mucopeptide and group-specific C polysaccharide 
antigens of Group A streptococcal cell walls were prepared by acid dissociation 
of immune precipitates, and labeled with either fluorescein or nsI. 
Employing both fluorescent and radioautographic procedures the persistence 
of the antigens was followed in skin sites injected with cell wall fragments. Both 
antigens persisted within macrophages for at least 54 days in those  animals 
which  developed  no  chronic  tissue  response.  In  animals  which  did  develop 
chronic nodular lesions the concentration of antigen decreased as the inflam- 
matory process subsided. Lesion activity was thus associated with the presence 
of cell wall material. 
The fate of these  antigens  was also determined  following  the  intradermal 
injection of intact Group A  streptococcal cells. Cell wall antigens persisted in 
the  tissue  site considerably longer  than morphologically identifiable  strepto- 
cocci,  indicating  that  cell  wall fragments are  released  during  dismantling  of 
streptococci in phagocytic cells. 
We wish to thank Dr. E. D. Day and Dr. J. Vazquez for their help in autoradiography 
studies and Dr. W. J. Cromartie for his advice on histological interpretation of tissue sections. 
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EXPLANATION OF PLATES 
PLATE 109 
FIGS.  1 a-1 d. Detection of streptococcal antigens in rabbit skin following intra- 
dermal injection of intact Group A streptococci. 
FIG. 1 a. 4 hr after injection, stained with fluorescein-labeled anti-A globulin, 25 
sec exposure.  ×  400. 
FIG. 1 b. Giemsa stain of Fig. 1 a, showing association of fluorescence with identi- 
fiable streptococci. X  500. 
FIc. 1 c.  18 days after injection, stained with fluorescein-labeled anti-A globulin, 
25 sec exposure.  X  400. 
FIG. 1 d. Giemsa stain of Fig. 1 c, showing absence of morphologically recognizable 
streptococci. ×  400. THE  JOURNAL  O1," EXPERIMENTAL  MEDICINE  VOL. 125  PLATE  109 
(Ohanian and Schwab: Group A streptococcal cell walls and inflammation) PLATE  110 
FIGS. 2 ~-2f. Detection of mucopeptide and C polysaccharide antigens in rabbit 
skin following injection of Group A streptococci. 
FIG. 2 a. 5 days after injection, stained with 125I anti-MP. X  845. 
FIG. 2 b. 5 days after injection, stained with 1~5I anti-CP. X  845. 
FIG, 2 c. 18 days after injection, stained with 12~I anti-MP. X  845. 
FIo. 2 d.  18 days after injection stained with 1~I anti-CP. X 845. 
FIC.  2 e.  21  days  after injection, stained with  mI anti-MP, showing absence of 
antigen. ×  375. 
FIG. 2f. 21 days after injection, stained with 125I anti-CP. X  375. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 125  PLATE  110 
(Ohanian and Schwab: Group A .streptococcal  cell walls and inflammation) PLATE 111 
FICS. 3 a-3 c. Primary nodular lesion 4 days after intradermal injection of group A 
cell  wall fragments, showing foci  of  PMN  leukocytes surrounded by mononuclear 
cells. Giemsa stain. 
FIG. 3 a.  X 88. 
FIG. 3 b.  X  830. 
FIG. 3 c, stained with ~25I anti-Group A CP.  X 365. 
FIGS. 3 d-3 f.  Consecutive tissue sections of control sites 8 hr after injection with 
Group D streptococcal cell wall fragments, showing failure of anti-Group A globulins 
to react with this control inflammatory tissue. 
FIG. 3 d. Stained with 1~I anti-Group AMP.  X 365. 
FIG. 3 e. Stained with 125I anti-Group A CP.  X 365. 
FIG. 3f. Stained with 12~I normal globulin. X 365. THE  SOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  125  PLATE  III 
(Ohanian and Schwab: Group A streptococcal cell walls and inflammation) PLATE 1 12 
FITS.  4 a4  e.  Localization  of  mucopeptide  and  C  polysaccharide  4  hr  after  in- 
iection of Group A cell wall fragments, and typical controls.  X  365. 
Fro. 4 a. Stained with 1251 anti-MP. 
FIG. 4 b. Antibody-blocked control of Fig. 4,a. 
FIG. 4 c. Stained with ~2~I anti-CP. 
FIG. 4 d. Antibody-blocked control of Fig. 4 c. 
F,G. 4 e. Stained with 1~5I normal globulin. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 125  PLATE  112 
(Ohanian and Schwab: Group A streptococcal cell walls and inflammation) PLATE 113 
FIGS. 5 a-Sf. Detection of mucopeptide and C polysaccharide at various stages of 
nodular lesion development following injection of  Group  A  streptococcal cell wall 
fragments.  X  365. 
FIo. 5 a. Late subsided primary nodular lesion 14 days after injection, stained with 
1~5I anti-MP. 
FIo. 5 b. Serial section of Fig. 5 a, stained with 125I anti-CP. 
FIO. 5 c. Relapsed nodular lesion, 48 hr after appearance, 27 days after injection, 
stained with anfi-MP. 
FIG. 5 d. Serial section of Fig. 5 c, stained with anti-CP. 
FIG. 5 e.  Subsiding relapsed nodular lesion, 30  days after injection, stained with 
anti-MP, showing absence of antigen. 
FIG. 5 f. Serial section of Fig. 5 e, stained with anti-CP. THE 3OURNAL  OF EXPERIMENTAL  MEDICINE  VOL. 125  PLATE  113 
(Ohanian and Schwab: Group A streptococcal cell walls and inflammation) P~ATE 114 
FIGS.  6 a-6f.  Detection of mucopeptide  and  C  polysaccharide  54  days  after  in- 
jection of Group A streptococcal cell wall fragments.  ×  390, 
Fro.  6 a.  Persistence of antigen  at injection site in  an  animal which did  not de- 
velop nodular lesions  during the period of observation. Stained with 125I anti-MP. 
FIG. 6 b. Serial section to Fig. 6 a. Stained with 125I anti-CP. 
Fro. 6 c. Tissue section from a second rabbit which did not develop nodular le~ions 
over a period of 54 days. Stained with 125I anti-MP. 
FIG. 6 d. Serial section to Fig. 6 c. Stained with 1~I anti-CP. 
FIG.  6 e.  Absence of  antigen  from  injection site of a  rabbit which had  developed 
only a primary nodular lesion and  had  been negative for 30 days.  Stained with ~25I 
anti-MP. 
Fro. 6f. Serial section to Fig. 6 e. Stained with 12~[ anti-CP. TkiE JOURNAL  OF EXPERIMENTAL  MEDICINE VOL. 125  PLATE 114 
(Ohanian and Schwab: Group A streptococcal cell walls and inflammation) 